Detalhe da pesquisa
1.
D3 Receptor-Targeted Cariprazine: Insights from Lab to Bedside.
Int J Mol Sci
; 25(11)2024 May 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-38891871
2.
The efficacy and safety of cariprazine in the early and late stage of schizophrenia: a post hoc analysis of three randomized, placebo-controlled trials.
CNS Spectr
; 28(1): 104-111, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35012696
3.
The burden of caring for someone with schizophrenia: A cross country report from Bulgaria, the Czech Republic, Hungary and Russia.
Psychiatr Hung
; 36(4): 546-556, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34939572
4.
[Cariprazine, a new type - dopamine D3 receptor preferring - partial agonist atypical antipsychotic for the treatment of schizophrenia and the primary negative symptoms]. / Kariprazin, egy új típusú dopamin D3 receptort preferáló parciális agonista atípusos antipszichotikum a szkizofrénia és primer negatív tüneteinek kezelésére.
Neuropsychopharmacol Hung
; 21(3): 103-118, 2019 Sep.
Artigo
em Húngaro
| MEDLINE | ID: mdl-31537751
5.
Cariprazine versus risperidone monotherapy for treatment of predominant negative symptoms in patients with schizophrenia: a randomised, double-blind, controlled trial.
Lancet
; 389(10074): 1103-1113, 2017 03 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-28185672
6.
Evaluation of the long-term safety and tolerability of cariprazine in patients with schizophrenia: results from a 1-year open-label study.
CNS Spectr
; 23(1): 39-50, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-28478771
7.
The safety and tolerability of cariprazine in long-term treatment of schizophrenia: a post hoc pooled analysis.
BMC Psychiatry
; 17(1): 305, 2017 08 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-28836957
8.
Global improvement with cariprazine in the treatment of bipolar I disorder and schizophrenia: A pooled post hoc analysis.
Int J Clin Pract
; 71(12)2017 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-29119668
9.
[Investigation of CNTF, COMT, DDR1, DISC1, DRD2, DRD3, and DTNBP1 candidate genes in schizophrenia: Results from the Hungarian SCHIZOBANK Consortium]. / CNTF, COMT, DDR1, DISC1, DRD2, DRD3 és DTNBP1 kandidáns gének vizsgálata szkizofréniában: eredmények a Magyar SCHIZOBANK Konzorcium vizsgálatából.
Neuropsychopharmacol Hung
; 18(4): 181-187, 2016 12.
Artigo
em Húngaro
| MEDLINE | ID: mdl-28259861
10.
The efficacy and tolerability of cariprazine in acute mania associated with bipolar I disorder: a phase II trial.
Bipolar Disord
; 17(1): 63-75, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25056368
11.
[New directions in biomarker research, drug development and personalized medicine]. / A személyre szabott medicina, a biomarker-kutatás és a gyógyszerfejlesztés új irányai.
Magy Onkol
; 57(1): 5-10, 2013 Mar.
Artigo
em Húngaro
| MEDLINE | ID: mdl-23573515
12.
[Significance of genetic tests in the era of personalized medicine]. / A genetikai tesztek jelentõsége a személyre szabott orvoslás korszakában.
Magy Onkol
; 57(1): 16-20, 2013 Mar.
Artigo
em Húngaro
| MEDLINE | ID: mdl-23573517
13.
The improvement of motor symptoms in Huntington's disease during cariprazine treatment.
Orphanet J Rare Dis
; 18(1): 375, 2023 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38041194
14.
[Human experiments in gypsies?] / Emberkísérlet cigányokkal?
Orv Hetil
; 158(44): 1761-1764, 2017 Nov.
Artigo
em Húngaro
| MEDLINE | ID: mdl-29086592
15.
[Vinpocetin in neurological diseases]. / Vinpocetin alkalmazása neurológiai kórképekben.
Ideggyogy Sz
; 65(11-12): 387-93, 2012 Nov 30.
Artigo
em Húngaro
| MEDLINE | ID: mdl-23289173
16.
What Is the Minimum Clinically Important Change in Negative Symptoms of Schizophrenia? PANSS Based Post-hoc Analyses of a Phase III Clinical Trial.
Front Psychiatry
; 13: 816339, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35546918
17.
Cariprazine, A Broad-Spectrum Antipsychotic for the Treatment of Schizophrenia: Pharmacology, Efficacy, and Safety.
Adv Ther
; 38(7): 3652-3673, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34091867
18.
Safety and Tolerability of Cariprazine in Patients with Schizophrenia: A Pooled Analysis of Eight Phase II/III Studies.
Neuropsychiatr Dis Treat
; 17: 957-970, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33854317
19.
The effectiveness and safety of cariprazine in schizophrenia patients with negative symptoms and insufficient effectiveness of previous antipsychotic therapy: an observational study.
Int Clin Psychopharmacol
; 36(3): 154-161, 2021 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33560040
20.
Disentangling the symptoms of schizophrenia: Network analysis in acute phase patients and in patients with predominant negative symptoms.
Eur Psychiatry
; 65(1): e18, 2021 10 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-34641986